Learn more about the Teleport Team!

Drugs for the Brain from the Brain

Endogenous neurotransmitters provide the starting point for Teleport Pharamceuticals' glycopeptide drugs for the treatment of degenerative neurological diseases. We are targeting neurogenerative diseases such as Alzheimer’s, Parkinson’s, and ALS or Lou Gehrig’s disease, as well as AIDS related neuropathy, diabetic neuropathy, autism, stroke and closed head injury. Teleport Pharmaceuticals is dedicated to novel peptide-based drug design for future therapeutics.

Get UpdatesContact Us
Founders of Teleport Pharmaceuticals